305 related articles for article (PubMed ID: 1350941)
1. Neuroendocrine differentiation in carcinoma of the prostate. Diagnostic, prognostic, and therapeutic implications.
di Sant'Agnese PA
Cancer; 1992 Jul; 70(1 Suppl):254-68. PubMed ID: 1350941
[TBL] [Abstract][Full Text] [Related]
2. Neuroendocrine differentiation in human prostatic carcinoma.
di Sant'Agnese PA
Hum Pathol; 1992 Mar; 23(3):287-96. PubMed ID: 1313390
[TBL] [Abstract][Full Text] [Related]
3. The prostatic endocrine-paracrine (neuroendocrine) regulatory system and neuroendocrine differentiation in prostatic carcinoma: a review and future directions in basic research.
Di Sant'Agnese PA; Cockett AT
J Urol; 1994 Nov; 152(5 Pt 2):1927-31. PubMed ID: 7933249
[TBL] [Abstract][Full Text] [Related]
4. Neuroendocrine cells of the prostate and neuroendocrine differentiation in prostatic carcinoma: a review of morphologic aspects.
di Sant'Agnese PA
Urology; 1998 May; 51(5A Suppl):121-4. PubMed ID: 9610566
[TBL] [Abstract][Full Text] [Related]
5. Neuroendocrine differentiation in prostatic malignancy.
di Sant'Agnese PA; Cockett AT
Cancer; 1996 Jul; 78(2):357-61. PubMed ID: 8674017
[TBL] [Abstract][Full Text] [Related]
6. Divergent neuroendocrine differentiation in prostatic carcinoma.
di Sant' Agnese PA
Semin Diagn Pathol; 2000 May; 17(2):149-61. PubMed ID: 10839615
[TBL] [Abstract][Full Text] [Related]
7. Evaluation and clinical value of neuroendocrine differentiation in human prostatic tumors.
Cussenot O; Villette JM; Cochand-Priollet B; Berthon P
Prostate Suppl; 1998; 8():43-51. PubMed ID: 9690663
[TBL] [Abstract][Full Text] [Related]
8. Neuroendocrine differentiation in the precursors of prostate cancer.
di Sant' Agnese PA
Eur Urol; 1996; 30(2):185-90. PubMed ID: 8875199
[TBL] [Abstract][Full Text] [Related]
9. Characterization of neuroendocrine differentiation in human benign prostate and prostatic adenocarcinoma.
Aprikian AG; Cordon-Cardo C; Fair WR; Reuter VE
Cancer; 1993 Jun; 71(12):3952-65. PubMed ID: 7685237
[TBL] [Abstract][Full Text] [Related]
10. Neuroendocrine differentiation in prostate carcinoma: focusing on its pathophysiologic mechanisms and pathological features.
Alberti C
G Chir; 2010; 31(11-12):568-74. PubMed ID: 21232206
[TBL] [Abstract][Full Text] [Related]
11. [Role of neuroendocrine cells in prostate cancer progression].
Sciarra A; Innocenzi M; Ravaziol M; Minisola F; Alfarone A; Cattarino S; Panebianco V; Buonocore V; Gentile V; Di Silverio F
Urologia; 2011; 78(2):126-31. PubMed ID: 21574145
[TBL] [Abstract][Full Text] [Related]
12. Endocrine-paracrine (APUD, neuroendocrine) cells in the normal and pathologic prostate.
Di Sant'agnese PA
Bull Assoc Anat (Nancy); 1991 Jun; 75(229):63-7. PubMed ID: 1685682
[No Abstract] [Full Text] [Related]
13. [Neuroendocrine differentiation in prostate cancer. An unrecognized and therapy-resistant phenotype].
Bonkhoff H; Fixemer T
Urologe A; 2004 Jul; 43(7):836-42. PubMed ID: 15048555
[TBL] [Abstract][Full Text] [Related]
14. Neuroendocrine differentiation in prostatic carcinoma.
Abrahamsson PA
Prostate; 1999 May; 39(2):135-48. PubMed ID: 10221570
[TBL] [Abstract][Full Text] [Related]
15. Neuroendocrine differentiation in prostatic carcinomas. A retrospective autopsy study.
Turbat-Herrera EA; Herrera GA; Gore I; Lott RL; Grizzle WE; Bonnin JM
Arch Pathol Lab Med; 1988 Nov; 112(11):1100-5. PubMed ID: 2460064
[TBL] [Abstract][Full Text] [Related]
16. Endocrine-paracrine cell types in the prostate and prostatic adenocarcinoma are postmitotic cells.
Bonkhoff H; Stein U; Remberger K
Hum Pathol; 1995 Feb; 26(2):167-70. PubMed ID: 7532147
[TBL] [Abstract][Full Text] [Related]
17. Neuroendocrine differentiation in prostatic carcinoma.
di Sant'Agnese PA; de Mesy Jensen KL
Hum Pathol; 1987 Aug; 18(8):849-56. PubMed ID: 3610135
[TBL] [Abstract][Full Text] [Related]
18. Acquisition of neuroendocrine characteristics by prostate tumor cells is reversible: implications for prostate cancer progression.
Cox ME; Deeble PD; Lakhani S; Parsons SJ
Cancer Res; 1999 Aug; 59(15):3821-30. PubMed ID: 10447001
[TBL] [Abstract][Full Text] [Related]
19. Plasma neuroendocrine markers in patients with benign prostatic hyperplasia and prostatic carcinoma.
Cussenot O; Villette JM; Valeri A; Cariou G; Desgrandchamps F; Cortesse A; Meria P; Teillac P; Fiet J; Le Duc A
J Urol; 1996 Apr; 155(4):1340-3. PubMed ID: 8632569
[TBL] [Abstract][Full Text] [Related]
20. Multidirectional differentiation in the normal, hyperplastic, and neoplastic human prostate: simultaneous demonstration of cell-specific epithelial markers.
Bonkhoff H; Stein U; Remberger K
Hum Pathol; 1994 Jan; 25(1):42-6. PubMed ID: 7508883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
